ArticleArthritis research & therapy2024

Changes in type VI collagen degradation reflect clinical response to treatment in rheumatoid arthritis patients treated with tocilizumab.

Christian S Thudium et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.